{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:52:11Z","timestamp":1785901931058,"version":"3.56.0"},"reference-count":124,"publisher":"Walter de Gruyter GmbH","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Thrombotic microangiopathy (TMA) is a relatively rare condition but a medical urgency requiring immediate intervention to avoid irreversible organ damage or death. Symptoms on presentation include microangiopathic haemolytic anaemia, thrombocytopenia and organ damage. The most frequent direct causes of TMA are thrombotic thrombocytopenic purpura (TTP) and haemolytic uremic syndrome (HUS). The most common form of HUS is related to Shiga toxin producing<\/jats:p>","DOI":"10.1515\/cclm-2015-0024","type":"journal-article","created":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T14:13:43Z","timestamp":1426688023000},"source":"Crossref","is-referenced-by-count":23,"title":["Atypical hemolytic uremic syndrome: from diagnosis to treatment"],"prefix":"10.1515","volume":"53","author":[{"given":"Massimo","family":"Franchini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","reference":[{"key":"ref251","first-page":"240","article-title":"de Gain - of - function mutations in complement factor are associated with atypical hemolytic uremic syndrome","author":"Goicoechea","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref1311","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00467-013-2722-2","article-title":"kidney transplantation to cure atypical still an option post - eculizumab","volume":"29","author":"Saland","year":"2014","journal-title":"Liver Pediatr Nephrol"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1111\/j.1600-6143.2012.04252.x","article-title":"Study Group for Atypical HUS for atypical hemolytic uremic syndrome recurrence in renal transplantation","volume":"12","author":"Zuber","year":"2012","journal-title":"Am J Transplant"},{"key":"ref971","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00467-008-0964-1","article-title":"European Paediatric Study Group for HUS Guideline for the investigation and initial therapy of diarrhea - negative hemolytic uremic syndrome","volume":"24","author":"Ariceta","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1385\/MB:26:2:117","article-title":"MA by toxin producing coli an overview","volume":"26","author":"Karmali","year":"2004","journal-title":"Infection Mol Biotechnol"},{"key":"ref501","first-page":"10208","article-title":"Reference Center for Thrombotic Microangiopathies Predictive features of severe acquired deficiency in idiopathic thrombotic microangiopathies : the TMA reference center experience One","volume":"13","author":"Coppo","year":"2010"},{"key":"ref781","first-page":"290","article-title":"Long - term renal prognosis of diarrhea - associated hemolytic uremic syndrome : a systematic review meta - analysis and meta - regression","author":"Garg","year":"2003","journal-title":"Am Med Assoc"},{"key":"ref91","first-page":"182","article-title":"toxin activates complement and binds factor evidence for an active role of complement in hemolytic uremic syndrome","author":"Orth","year":"2009","journal-title":"J Immunol"},{"key":"ref421","first-page":"157","article-title":"The central Scotland Escherichia coli outbreak risk factors for the hemolytic uremic syndrome and death among hospitalized patients","volume":"31","author":"Dundas","year":"2001","journal-title":"AI PS Clin Infect Dis"},{"key":"ref1111","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/ki.2010.174","article-title":"Chronic renal disease is more prevalent in patients with hemolytic uremic syndrome who had a positive history of diarrhea","author":"Sharma","year":"2010","journal-title":"Kidney Int"},{"key":"ref231","first-page":"365","article-title":"an der Investigation Team Epidemic profile of toxin - producing Escherichia coli outbreak in","author":"Frank","year":"2011","journal-title":"Engl J Med"},{"key":"ref341","first-page":"5","article-title":"Management of thrombotic thrombocytopenic purpura current perspectives","author":"Blombery","year":"2014","journal-title":"Blood Med"},{"key":"ref771","first-page":"182","article-title":"toxin activates complement and binds factor evidence for an active role of complement in hemolytic uremic syndrome","author":"Orth","year":"2009","journal-title":"J Immunol"},{"key":"ref1211","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.molimm.2013.05.224","article-title":"therapy in atypical haemolytic uraemic syndrome aHUS","author":"Wong EK","year":"2013","journal-title":"Complement Mol Immunol"},{"key":"ref651","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/ajt.12077","article-title":"genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome","volume":"13","author":"Le Quintrec","year":"2013","journal-title":"Complement Am J Transplant"},{"key":"ref811","first-page":"361","article-title":"Atypical hemolytic uremic syndrome","author":"Noris","year":"2009","journal-title":"Engl J Med"},{"key":"ref171","first-page":"422","article-title":"de of atypical hemolytic uremic syndrome aHUS","volume":"30","author":"Rodriguez","year":"2014","journal-title":"Genetics Semin Thromb Hemost"},{"key":"ref1251","first-page":"368","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic - uremic syndrome","author":"Legendre","year":"2013","journal-title":"Engl J Med"},{"key":"ref661","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.trre.2013.07.003","article-title":"Targeted strategies in the prevention and management of atypical HUS recurrence after kidney transplantation","volume":"27","author":"Zuber","year":"2013","journal-title":"Transplant Rev"},{"key":"ref131","first-page":"361","article-title":"Atypical hemolytic uremic syndrome","author":"Noris","year":"2009","journal-title":"Engl J Med"},{"key":"ref721","first-page":"89","article-title":"Deficient activity of von Willebrand factor - cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura","author":"Furlan","year":"1997","journal-title":"Blood"},{"key":"ref1021","first-page":"5","article-title":"Management of thrombotic thrombocytopenic purpura current perspectives","author":"Blombery","year":"2014","journal-title":"Blood Med"},{"key":"ref401","first-page":"117","article-title":"Pavia AT Predictors of fatality in postdiarrheal hemolytic uremic syndrome","author":"Oakes","year":"2006","journal-title":"Pediatrics"},{"key":"ref361","first-page":"139","article-title":"JE thrombocytopenic report of cases of the literature","volume":"16","author":"Amorosi","year":"1966","journal-title":"review Medicine"},{"key":"ref761","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1385\/MB:26:2:117","article-title":"MA by toxin producing coli an overview","volume":"26","author":"Karmali","year":"2004","journal-title":"Infection Mol Biotechnol"},{"key":"ref981","first-page":"21","article-title":"thrombosis of the terminal arterioles and capillaries : a hitherto undescribed disease","volume":"24","author":"Moschcowitz","year":"1924","journal-title":"Proc Soc"},{"key":"ref1291","article-title":"Walle Increased understanding of atypical haemolytic uraemic syndrome aHUS characteristics of patients recruited into the global aHUS registry Transplant ahead of print","author":"Vande","year":"2014"},{"key":"ref481","article-title":"Extra - renal manifestations of complement - mediated thrombotic microangiopathies Front","author":"Hofer","year":"2014"},{"key":"ref581","first-page":"849","article-title":"Eculizumab ECU inhibits thrombotic microangiopathy TMA and improves renal function in pediatric atypical hemolytic uremic syndrome aHUS patients pts Presented at American of Kidney Week Atlanta November Abstract SA - PO","author":"Greenbaum LA","year":"2013","journal-title":"Society Nephrology"},{"key":"ref1331","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/ajt.12077","article-title":"genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome","volume":"13","author":"Le Quintrec","year":"2013","journal-title":"Complement Am J Transplant"},{"key":"ref941","first-page":"112","article-title":"Mutations in complement predispose to development of atypical hemolytic uremic syndrome","author":"Fremeaux","year":"2008","journal-title":"Blood"},{"key":"ref681","first-page":"157","article-title":"HM The use of activity platelet count and serum creatinine to differentiate acquired thrombotic thrombocytopenic purpura from other thrombotic microangiopathies","volume":"13","author":"Cataland","year":"2012"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.mop.0000152997.66070.e9","article-title":"uremic syndrome pathogenesis treatment outcome","volume":"17","author":"Siegler","year":"2005","journal-title":"Curr Opin Pediatr"},{"key":"ref41","first-page":"89","article-title":"Deficient activity of von Willebrand factor - cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura","author":"Furlan","year":"1997","journal-title":"Blood"},{"key":"ref311","first-page":"99","article-title":"Mutations and common polymorphisms in gene responsible for von Willebrand factor - cleaving protease activity","volume":"13","author":"Kokame","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"ref1141","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.V961126","article-title":"The pathogenesis and treatment of hemolytic uremic syndrome","author":"Kaplan","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"ref1341","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.trre.2013.07.003","article-title":"Targeted strategies in the prevention and management of atypical HUS recurrence after kidney transplantation","volume":"27","author":"Zuber","year":"2013","journal-title":"Transplant Rev"},{"key":"ref01","first-page":"157","article-title":"HM The use of activity platelet count and serum creatinine to differentiate acquired thrombotic thrombocytopenic purpura from other thrombotic microangiopathies","volume":"13","author":"Cataland","year":"2012"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1681\/ASN.2012090903","article-title":"An II variants cause a glomerular microangiopathy that mimics membranoproliferative","volume":"24","author":"Ozaltin","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"ref861","first-page":"25","article-title":"Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome","author":"Maga","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"ref851","first-page":"422","article-title":"de of atypical hemolytic uremic syndrome aHUS","volume":"30","author":"Rodriguez","year":"2014","journal-title":"Genetics Semin Thromb Hemost"},{"key":"ref1151","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1111\/j.1600-6143.2012.04252.x","article-title":"Study Group for Atypical HUS for atypical hemolytic uremic syndrome recurrence in renal transplantation","volume":"12","author":"Zuber","year":"2012","journal-title":"Am J Transplant"},{"key":"ref161","first-page":"371","article-title":"CM Syndromes of thrombotic microangiopathy","author":"George","year":"2014","journal-title":"Engl J Med"},{"key":"ref1081","first-page":"117","article-title":"Pavia AT Predictors of fatality in postdiarrheal hemolytic uremic syndrome","author":"Oakes","year":"2006","journal-title":"Pediatrics"},{"key":"ref1031","first-page":"142","article-title":"Regional registry correlation with laboratory analysis and clinical features","volume":"13","author":"Scully","year":"2008"},{"key":"ref841","first-page":"371","article-title":"CM Syndromes of thrombotic microangiopathy","author":"George","year":"2014","journal-title":"Engl J Med"},{"key":"ref211","first-page":"112","article-title":"- phenotype correlation in congenital deficient patients Abstract","volume":"13","author":"Lotta LA","year":"2008","journal-title":"Blood"},{"key":"ref521","first-page":"115","article-title":"Survival and relapse in patients with thrombotic thrombocytopenic purpura","volume":"11","author":"Kremer Hovinga","year":"2010","journal-title":"Blood"},{"key":"ref281","first-page":"59","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref371","first-page":"85","article-title":"- uremic syndrome : bilateral necrosis of the renal cortex in acute acquired hemolytic anemia Schweiz","author":"Gasser","year":"1955","journal-title":"Med"},{"key":"ref691","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/sj.ki.5001581","article-title":"classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders","volume":"31","author":"Besbas","year":"2006","journal-title":"Kidney Int"},{"key":"ref701","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00467-010-1637-4","article-title":"Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy","volume":"26","author":"Keir","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"ref351","first-page":"142","article-title":"Regional registry correlation with laboratory analysis and clinical features","volume":"13","author":"Scully","year":"2008"},{"key":"ref1051","first-page":"85","article-title":"- uremic syndrome : bilateral necrosis of the renal cortex in acute acquired hemolytic anemia Schweiz","author":"Gasser","year":"1955","journal-title":"Med"},{"key":"ref931","first-page":"240","article-title":"de Gain - of - function mutations in complement factor are associated with atypical hemolytic uremic syndrome","author":"Goicoechea","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00467-010-1637-4","article-title":"Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy","volume":"26","author":"Keir","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"ref181","first-page":"25","article-title":"Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome","author":"Maga","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"ref611","article-title":"Walle Increased understanding of atypical haemolytic uraemic syndrome aHUS characteristics of patients recruited into the global aHUS registry Transplant ahead of print","author":"Vande","year":"2014"},{"key":"ref241","first-page":"108","article-title":"International Registry of Recurrent and Familial of the impact of and IF mutations on clinical presentation response to treatment outcome","author":"Caprioli","year":"2006","journal-title":"Genetics Blood"},{"key":"ref821","first-page":"1","article-title":"Hypocomplementaemia due to a genetic deficiency of beta globulin","author":"Thompson","year":"1981","journal-title":"Clin Exp Immunol"},{"key":"ref121","first-page":"27","article-title":"An update for atypical haemolytic uraemic syndrome diagnosis and treatment consensus document","volume":"33","author":"Campistol","year":"2013","journal-title":"Nefrologia"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/ki.2010.174","article-title":"Chronic renal disease is more prevalent in patients with hemolytic uremic syndrome who had a positive history of diarrhea","author":"Sharma","year":"2010","journal-title":"Kidney Int"},{"key":"ref71","first-page":"1","article-title":"Sporadic cases of haemolytic - uraemic syndrome associated with faecal cytotoxin and cytotoxin - producing Escherichia coli in stools","volume":"20","author":"Karmali","year":"1983","journal-title":"Lancet"},{"key":"ref411","first-page":"157","article-title":"Surveillance of hemolytic uremic syndrome in children less than years of age a system to monitor non - Shiga toxin - producing Escherichia coli infections in France","volume":"15","author":"Espie","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"ref711","first-page":"164","article-title":"How treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome","author":"Scully","year":"2014"},{"key":"ref1101","first-page":"157","article-title":"The central Scotland Escherichia coli outbreak risk factors for the hemolytic uremic syndrome and death among hospitalized patients","volume":"31","author":"Dundas","year":"2001","journal-title":"AI PS Clin Infect Dis"},{"key":"ref951","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1681\/ASN.2006080811","article-title":"of Pediatric Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome","volume":"18","author":"Sellier","year":"2007","journal-title":"Society Nephrology J Am Soc Nephrol"},{"key":"ref111","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2004100861","article-title":"uremic syndrome","volume":"16","author":"Noris","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ejim.2013.05.007","article-title":"HM Atypical hemolytic uremic syndrome and thrombotic thrombocytopenic purpura : clinically differentiating the thrombotic microangiopathies","volume":"24","author":"Cataland","year":"2013","journal-title":"Eur J Intern Med"},{"key":"ref1241","first-page":"360","article-title":"Eculizumab for congenital atypical hemolytic - uremic syndrome","author":"Gruppo","year":"2009","journal-title":"Engl J Med"},{"key":"ref901","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3324\/haematol.2008.002493","article-title":"Inherited thrombotic thrombocytopenic purpura","author":"Galbusera","year":"2009","journal-title":"Haematologica"},{"key":"ref101","first-page":"290","article-title":"Long - term renal prognosis of diarrhea - associated hemolytic uremic syndrome : a systematic review meta - analysis and meta - regression","author":"Garg","year":"2003","journal-title":"Am Med Assoc"},{"key":"ref891","first-page":"112","article-title":"- phenotype correlation in congenital deficient patients Abstract","volume":"13","author":"Lotta LA","year":"2008","journal-title":"Blood"},{"key":"ref911","first-page":"365","article-title":"an der Investigation Team Epidemic profile of toxin - producing Escherichia coli outbreak in","author":"Frank","year":"2011","journal-title":"Engl J Med"},{"key":"ref601","first-page":"73","article-title":"a review of its use in atypical haemolytic uraemic syndrome","author":"Keating","year":"2013","journal-title":"Drugs"},{"key":"ref1091","first-page":"157","article-title":"Surveillance of hemolytic uremic syndrome in children less than years of age a system to monitor non - Shiga toxin - producing Escherichia coli infections in France","volume":"15","author":"Espie","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"ref461","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.V961126","article-title":"The pathogenesis and treatment of hemolytic uremic syndrome","author":"Kaplan","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"ref551","first-page":"124","article-title":"Dynamics of complement activation in aHUS and how to monitor eculizumab therapy","volume":"26","author":"Noris","year":"2014","journal-title":"Blood"},{"key":"ref671","doi-asserted-by":"crossref","DOI":"10.1007\/s00467-009-1188-8","article-title":"Prophylactic plasma exchange in CD associated atypical haemolytic uremic syndrome","volume":"24","author":"Davin","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"ref331","first-page":"101","article-title":"von Willebrand factor cleaving protease mutations in childhood","volume":"13","author":"Schneppenheim","year":"2003","journal-title":"Blood"},{"key":"ref561","first-page":"360","article-title":"Eculizumab for congenital atypical hemolytic - uremic syndrome","author":"Gruppo","year":"2009","journal-title":"Engl J Med"},{"key":"ref961","first-page":"59","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref321","first-page":"1","article-title":"of syndrome based on gene analysis in Japan","volume":"13","author":"Fujimura","year":"2011","journal-title":"Natural history J Thromb Haemost"},{"key":"ref1231","first-page":"124","article-title":"Dynamics of complement activation in aHUS and how to monitor eculizumab therapy","volume":"26","author":"Noris","year":"2014","journal-title":"Blood"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.molimm.2013.05.224","article-title":"therapy in atypical haemolytic uraemic syndrome aHUS","author":"Wong EK","year":"2013","journal-title":"Complement Mol Immunol"},{"key":"ref571","first-page":"368","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic - uremic syndrome","author":"Legendre","year":"2013","journal-title":"Engl J Med"},{"key":"ref1351","doi-asserted-by":"crossref","DOI":"10.1007\/s00467-009-1188-8","article-title":"Prophylactic plasma exchange in CD associated atypical haemolytic uremic syndrome","volume":"24","author":"Davin","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00467-008-0964-1","article-title":"European Paediatric Study Group for HUS Guideline for the investigation and initial therapy of diarrhea - negative hemolytic uremic syndrome","volume":"24","author":"Ariceta","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"ref1301","first-page":"53","article-title":"Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient","author":"Chan","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"ref141","first-page":"1","article-title":"Hypocomplementaemia due to a genetic deficiency of beta globulin","author":"Thompson","year":"1981","journal-title":"Clin Exp Immunol"},{"key":"ref61","first-page":"339","article-title":"von Willebrand factor - cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic - uremic syndrome","author":"Furlan","year":"1998","journal-title":"Engl J Med"},{"key":"ref631","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00467-013-2722-2","article-title":"kidney transplantation to cure atypical still an option post - eculizumab","volume":"29","author":"Saland","year":"2014","journal-title":"Liver Pediatr Nephrol"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.ajkd.2004.02.010","article-title":"Non - enteropathic hemolytic uremic syndrome causes and short - term course","author":"Constantinescu","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"ref1261","first-page":"849","article-title":"Eculizumab ECU inhibits thrombotic microangiopathy TMA and improves renal function in pediatric atypical hemolytic uremic syndrome aHUS patients pts Presented at American of Kidney Week Atlanta November Abstract SA - PO","author":"Greenbaum LA","year":"2013","journal-title":"Society Nephrology"},{"key":"ref921","first-page":"108","article-title":"International Registry of Recurrent and Familial of the impact of and IF mutations on clinical presentation response to treatment outcome","author":"Caprioli","year":"2006","journal-title":"Genetics Blood"},{"key":"ref51","first-page":"339","article-title":"HM EC Antibodies to von Willebrand factor - cleaving protease in acute thrombotic thrombocytopenic purpura","author":"Tsai","year":"1998","journal-title":"Engl J Med"},{"key":"ref881","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1681\/ASN.2012090903","article-title":"An II variants cause a glomerular microangiopathy that mimics membranoproliferative","volume":"24","author":"Ozaltin","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"ref731","first-page":"339","article-title":"HM EC Antibodies to von Willebrand factor - cleaving protease in acute thrombotic thrombocytopenic purpura","author":"Tsai","year":"1998","journal-title":"Engl J Med"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1681\/ASN.2006080811","article-title":"of Pediatric Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome","volume":"18","author":"Sellier","year":"2007","journal-title":"Society Nephrology J Am Soc Nephrol"},{"key":"ref1201","first-page":"115","article-title":"Survival and relapse in patients with thrombotic thrombocytopenic purpura","volume":"11","author":"Kremer Hovinga","year":"2010","journal-title":"Blood"},{"key":"ref1121","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.ajkd.2004.02.010","article-title":"Non - enteropathic hemolytic uremic syndrome causes and short - term course","author":"Constantinescu","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"ref1281","first-page":"73","article-title":"a review of its use in atypical haemolytic uraemic syndrome","author":"Keating","year":"2013","journal-title":"Drugs"},{"key":"ref261","first-page":"112","article-title":"Mutations in complement predispose to development of atypical hemolytic uremic syndrome","author":"Fremeaux","year":"2008","journal-title":"Blood"},{"key":"ref1071","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.mop.0000152997.66070.e9","article-title":"uremic syndrome pathogenesis treatment outcome","volume":"17","author":"Siegler","year":"2005","journal-title":"Curr Opin Pediatr"},{"key":"ref1001","first-page":"1","article-title":"of syndrome based on gene analysis in Japan","volume":"13","author":"Fujimura","year":"2011","journal-title":"Natural history J Thromb Haemost"},{"key":"ref801","first-page":"27","article-title":"An update for atypical haemolytic uraemic syndrome diagnosis and treatment consensus document","volume":"33","author":"Campistol","year":"2013","journal-title":"Nefrologia"},{"key":"ref991","first-page":"99","article-title":"Mutations and common polymorphisms in gene responsible for von Willebrand factor - cleaving protease activity","volume":"13","author":"Kokame","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"ref1011","first-page":"101","article-title":"von Willebrand factor cleaving protease mutations in childhood","volume":"13","author":"Schneppenheim","year":"2003","journal-title":"Blood"},{"key":"ref831","first-page":"53","article-title":"Genetic studies into inherited and sporadic hemolytic uremic syndrome","author":"Warwicker","year":"1998","journal-title":"Kidney Int"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/sj.ki.5001581","article-title":"classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders","volume":"31","author":"Besbas","year":"2006","journal-title":"Kidney Int"},{"key":"ref31","first-page":"164","article-title":"How treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome","author":"Scully","year":"2014"},{"key":"ref871","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic - uremic syndrome","author":"Lemaire","year":"2013","journal-title":"Nat Genet"},{"key":"ref751","first-page":"1","article-title":"Sporadic cases of haemolytic - uraemic syndrome associated with faecal cytotoxin and cytotoxin - producing Escherichia coli in stools","volume":"20","author":"Karmali","year":"1983","journal-title":"Lancet"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng.2590","article-title":"Recessive mutations in DGKE cause atypical hemolytic - uremic syndrome","author":"Lemaire","year":"2013","journal-title":"Nat Genet"},{"key":"ref1161","article-title":"Extra - renal manifestations of complement - mediated thrombotic microangiopathies Front","author":"Hofer","year":"2014"},{"key":"ref151","first-page":"53","article-title":"Genetic studies into inherited and sporadic hemolytic uremic syndrome","author":"Warwicker","year":"1998","journal-title":"Kidney Int"},{"key":"ref741","first-page":"339","article-title":"von Willebrand factor - cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic - uremic syndrome","author":"Furlan","year":"1998","journal-title":"Engl J Med"},{"key":"ref621","first-page":"53","article-title":"Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient","author":"Chan","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3324\/haematol.2008.002493","article-title":"Inherited thrombotic thrombocytopenic purpura","author":"Galbusera","year":"2009","journal-title":"Haematologica"},{"key":"ref301","first-page":"21","article-title":"thrombosis of the terminal arterioles and capillaries : a hitherto undescribed disease","volume":"24","author":"Moschcowitz","year":"1924","journal-title":"Proc Soc"},{"key":"ref1171","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ejim.2013.05.007","article-title":"HM Atypical hemolytic uremic syndrome and thrombotic thrombocytopenic purpura : clinically differentiating the thrombotic microangiopathies","volume":"24","author":"Cataland","year":"2013","journal-title":"Eur J Intern Med"},{"key":"ref791","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2004100861","article-title":"uremic syndrome","volume":"16","author":"Noris","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref1181","first-page":"10208","article-title":"Reference Center for Thrombotic Microangiopathies Predictive features of severe acquired deficiency in idiopathic thrombotic microangiopathies : the TMA reference center experience One","volume":"13","author":"Coppo","year":"2010"},{"key":"ref1041","first-page":"139","article-title":"JE thrombocytopenic report of cases of the literature","volume":"16","author":"Amorosi","year":"1966","journal-title":"review Medicine"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2015-0024\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T09:58:35Z","timestamp":1651571915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2015-0024\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,1]]},"references-count":124,"journal-issue":{"issue":"11"},"URL":"https:\/\/doi.org\/10.1515\/cclm-2015-0024","relation":{},"ISSN":["1437-4331","1434-6621"],"issn-type":[{"value":"1437-4331","type":"electronic"},{"value":"1434-6621","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1,1]]}}}